Asthma COPD Clinical Trial
Official title:
Phase 1 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, PK, and PD of Single Ascending Doses of KN-002 in Healthy Subjects and Multiple Ascending Doses of KN-002 in Subjects With Mild Asthma, Moderate-Severe Asthma and COPD
This is a Phase 1, randomized, double-blinded, placebo controlled study. The study consists of 4 parts: Part 1 is a single ascending dose (SAD) study in healthy volunteers; Part 2 is a multiple ascending dose (MAD) study in subjects with stable, mild asthma; Part 3 is a repeat dose in patients with moderate to severe asthma and Part 4 is a repeat dose in patients with COPD.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06099145 -
Clinical and Medico-economic Validation of the HEPHAI Solution.
|
N/A | |
| Completed |
NCT06417931 -
Medication Adherence and Use of Inhaler Devices in Patients With Asthma or COPD
|
N/A | |
| Completed |
NCT05764343 -
The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases
|
N/A | |
| Recruiting |
NCT06039943 -
Relationship Between Acoustic Breath Sounds and Spirometry
|
N/A | |
| Recruiting |
NCT05299385 -
The Study for Evaluating the Clinical Effectiveness and Safety of Respiratory Rehabilitation Software 'Redpill Breath'(COPD, Asthma, Lung Cancer, Etc.)
|
Phase 3 | |
| Active, not recruiting |
NCT04341701 -
Phenotype Identification Based on Multimodal MRI Analysis of Patients With Bronchial Obstructive Diseases
|
N/A | |
| Recruiting |
NCT04233190 -
A Multicenter, Randomized, Parallel, Two-Period, Non-Inferiority Study of EurofarmavsAlenia in Asthma and COPD Treatment
|
Phase 3 |